Santen Pharmaceutical Co Stock Market Value
| SNPHY Stock | USD 10.61 0.39 3.55% |
| Symbol | Santen |
Santen Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Santen Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Santen Pharmaceutical.
| 06/04/2024 |
| 12/01/2024 |
If you would invest 0.00 in Santen Pharmaceutical on June 4, 2024 and sell it all today you would earn a total of 0.00 from holding Santen Pharmaceutical Co or generate 0.0% return on investment in Santen Pharmaceutical over 180 days. Santen Pharmaceutical is related to or competes with Sanofi ADR, Bristol Myers, AstraZeneca PLC, Gilead Sciences, and Novartis. Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices i... More
Santen Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Santen Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Santen Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 18.94 | |||
| Value At Risk | (4.60) | |||
| Potential Upside | 5.87 |
Santen Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Santen Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Santen Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Santen Pharmaceutical historical prices to predict the future Santen Pharmaceutical's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | 2.58 |
Santen Pharmaceutical Backtested Returns
Santen Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0537, which indicates the firm had a -0.0537% return per unit of risk over the last 3 months. Santen Pharmaceutical Co exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Santen Pharmaceutical's Coefficient Of Variation of (1,405), risk adjusted performance of (0.05), and Variance of 10.94 to confirm the risk estimate we provide. The entity has a beta of -0.0953, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Santen Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Santen Pharmaceutical is likely to outperform the market. At this point, Santen Pharmaceutical has a negative expected return of -0.18%. Please make sure to validate Santen Pharmaceutical's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Santen Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.82 |
Excellent reverse predictability
Santen Pharmaceutical Co has excellent reverse predictability. Overlapping area represents the amount of predictability between Santen Pharmaceutical time series from 4th of June 2024 to 2nd of September 2024 and 2nd of September 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Santen Pharmaceutical price movement. The serial correlation of -0.82 indicates that around 82.0% of current Santen Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.82 | |
| Spearman Rank Test | -0.78 | |
| Residual Average | 0.0 | |
| Price Variance | 0.53 |
Santen Pharmaceutical lagged returns against current returns
Autocorrelation, which is Santen Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Santen Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Santen Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Santen Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Santen Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Santen Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Santen Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Santen Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Santen Pharmaceutical Lagged Returns
When evaluating Santen Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Santen Pharmaceutical pink sheet have on its future price. Santen Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Santen Pharmaceutical autocorrelation shows the relationship between Santen Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Santen Pharmaceutical Co.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Santen Pink Sheet Analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.